Key Takeaways

  • GP-led continuation vehicles now represent roughly half of the entire secondary market, shifting from an emergency liquidity valve into a standard tool for active portfolio management.
  • HarbourVest deployed $11 billion into private equity secondaries over the past year, directing $5.5 billion straight into continuation vehicles.
  • Early performance data shows assets moved into continuation funds deliver better than median returns compared to their original vintage years.
  • Toomey warns against over-negotiating terms against selling LPs, because overly aggressive alignment invites the same penalty when the new buyer exits years later.
  • HarbourVest evaluates every GP-led transaction using the HarbourVest Continuation Vehicle (CV) Underwriting Framework.

The HarbourVest Continuation Vehicle (CV) Underwriting Framework

Manager Calibration

Require an established relationship with the GP. It must be a manager HarbourVest knows, has properly calibrated, and has concrete insight on their capabilities and track record.

Asset Track Record Calibration

Target companies with demonstrable operating history under the sponsor. These are companies that are well-calibrated through years of realized performance, giving buyers historical data to assess how they operated under private equity ownership.

Strategic Context and Coherent Thesis

Verify the underlying rationale for holding the company longer. The context matters: the manager needs a coherent thesis explaining why they want to move the asset into a continuation vehicle rather than pursuing an outright sale.

General Partner Reinvestment and Roll

Inspect GP skin-in-the-game. Underwriters look directly at how much capital the manager will roll over from existing carried interest and whether they are investing fresh balance sheet capital into the vehicle.

Quick-Flip and Recap Protections

Implement structural provisions against immediate exits. The terms must protect the vehicle if a manager sells the company 6, 12, or 18 months after rolling it into a continuation fund.

Balanced Alignment Test

Avoid over-extracting terms that harm existing fund investors. If the incoming terms are too lopsided against selling LPs, it signals that the buyer will face that exact disadvantage when the GP sells the business three or four years later.

When This Works (and When It Doesn't)

This framework works when an institution evaluates whether to underwrite, roll into, or cash out of a GP-led continuation vehicle. It applies best to single-asset or concentrated multi-asset deals where the business has a verifiable operating track record under the sponsor. Buyers can examine actual EBITDA trajectory, acquisition integration, and multiple expansion under the incumbent management team rather than buying blind projections.

It breaks down when applied to distressed recaps or cross-fund transfers of underperforming assets. If a GP uses a continuation fund to kick a broken asset down the road without committing substantial fresh capital, manager calibration cannot fix a broken balance sheet. It also falters when secondary buyers mistake heavy discounts for structural protection: an asset with poor organic cash flow will fail regardless of how favorable the incoming terms look.

Why It Matters

Private equity spent decades operating on a rigid ten-year fund cycle where general partners routinely sold their strongest assets to competitors simply because the clock ran out. Continuation vehicles break that cycle. By committing $5.5 billion to CVs in twelve months, HarbourVest confirms that the top assets in private equity are increasingly staying in-house for secondary runs. This removes trophy companies from the traditional sponsor-to-sponsor buyout pipeline, forcing standard buyout funds to hunt in more contested, lower-quality corners of the market.